Unlock stock picks and a broker-level newsfeed that powers Wall Street.
TSXV - Delayed Quote CAD

Evome Medical Technologies Inc. (EVMT.V)

Compare
0.0850
0.0000
(0.00%)
At close: March 28 at 11:00:21 AM EDT
Loading Chart for EVMT.V
  • Previous Close 0.0850
  • Open 0.0850
  • Bid 0.0850 x --
  • Ask 0.0950 x --
  • Day's Range 0.0850 - 0.0850
  • 52 Week Range 0.0750 - 0.2950
  • Volume 11,000
  • Avg. Volume 66,798
  • Market Cap (intraday) 7.03M
  • Beta (5Y Monthly) 1.70
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2900
  • Earnings Date Mar 31, 2025 - Apr 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 24, 2017
  • 1y Target Est --

Evome Medical Technologies Inc. develops, manufactures, and distributes medical devices and products in the Americas and internationally. The company's product portfolio includes various devices for pain management and physical therapy treatments, including isokinetic dynamometers, perturbation gait trainers, balance assessment and recovery devices, neuromuscular electrical and transcutaneous electrical nerve stimulation devices, ultrasound treatment devices, wearable technology, and other products designed for the prevention, treatment, and rehabilitation of the human body. It offers SpaceTek Knee Device, a portable compact dynamometer isokinetic testing and rehabilitation device designed for small clinics; and Reactive Step Trainer that provides reproducible task-specific step perturbation to physical therapists, athletic trainers, orthopedic surgeons, hospitals, universities, research centers and healthcare distributors. In addition, the company offers assembly, packaging, and printing solutions to medical, construction, consumer products, and original equipment manufacturer companies. Further, it provides end-to-end solutions for medical device supply chains, including production, packaging, and servicing, as well as repair services; services for mechanical and electrical design and engineering, design and human factors, software and web development, and applied research and algorithm development; and products and supplies for capital equipment furnishings, capital equipment modalities, preventative care, and injury and rehabilitation to athletic trainers, physical therapists, and sports institutions. Additionally, the company offers design layout services to hospitals, private practice, rehabilitation, long-term care, and sports medicine markets. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. Evome Medical Technologies Inc. is headquartered in Shirley, New York.

www.evomemedical.com

195

Full Time Employees

December 31

Fiscal Year Ends

Recent News: EVMT.V

View More

Performance Overview: EVMT.V

Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

EVMT.V
29.17%
S&P/TSX Composite index (^GSPTSE)
0.56%

1-Year Return

EVMT.V
62.22%
S&P/TSX Composite index (^GSPTSE)
11.69%

3-Year Return

EVMT.V
85.09%
S&P/TSX Composite index (^GSPTSE)
12.66%

5-Year Return

EVMT.V
30.39%
S&P/TSX Composite index (^GSPTSE)
95.14%

Compare To: EVMT.V

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: EVMT.V

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    7.03M

  • Enterprise Value

    23.08M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.16

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    0.48

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -51.88%

  • Return on Assets (ttm)

    -45.69%

  • Return on Equity (ttm)

    -294.80%

  • Revenue (ttm)

    45.36M

  • Net Income Avi to Common (ttm)

    -23.53M

  • Diluted EPS (ttm)

    -0.2900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.41M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: EVMT.V

View More

Company Insights: EVMT.V

Research Reports: EVMT.V

View More

People Also Watch